Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients.
Giulio Francesco RomitiBernadette CoricaEugenia PipitoneMarco VitoloValeria RaparelliStefania BasiliGiuseppe BorianiSergio HarariGregory Y H LipMarco Proiettinull nullPublished in: European heart journal (2021)
COPD is common in AF, being found in 13% of patients, and is associated with increased burden of comorbidities, differential management, and worse outcomes, with more than a two-fold higher risk of all-cause death and increased risk of CV death and major bleeding. Therapy with BBs does not increase the risk of adverse outcomes in patients with AF and COPD.
Keyphrases
- atrial fibrillation
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic obstructive pulmonary disease
- heart failure
- prognostic factors
- type diabetes
- lung function
- cystic fibrosis
- coronary artery disease
- skeletal muscle
- mesenchymal stem cells
- left atrial
- direct oral anticoagulants
- mitral valve
- glycemic control
- replacement therapy
- weight loss